Aeglea BioTherapeutics | Mergers and Acquisitions Presentation Deck | 50 slides · page 37 of 50
The slide uses a biological process diagram to illustrate drug targets (a4b7, TL1A, IL-23) and their corresponding therapeutic antibodies.
Deck · other · present_solution · dense density
Slide locked Sign in to view
Slide schematic 6/6
callout 1/1 image 1/1 paragraph 3/3 title 1/1
Components 6
primary infographic paragraph paragraph paragraph headline
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 0
∅
No frameworks
No framework match is anchored to this slide.